CYFUSE BIOMEDICAL K K financial statements, including revenue, expenses, profit, and loss

The total revenue of 4892 for the last quarter is 8.27 M JPY, and it's 13.29% higher compared to the previous quarter. The net income of Q3 24 is -216.97 M JPY.